Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.43
+0.13 (1.78%)
At close: Aug 14, 2026, 4:00 PM EDT
7.44
0.00 (0.07%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Precision BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 45.06 | 34.26 | 68.7 | 48.73 | 25.1 | 115.53 | |
Revenue Growth | 3472.96% | -50.12% | 40.98% | 94.15% | -78.28% | 375.72% |
Gross Profit | 45.06 | 34.26 | 68.7 | 48.73 | 25.1 | 115.53 |
Selling, General & Admin | 28.13 | 32.24 | 35.3 | 39.09 | 43.34 | 43.23 |
Research & Development | 53.32 | 54.17 | 59.56 | 53.38 | 44.07 | 111.68 |
Operating Expenses | 81.45 | 86.41 | 94.86 | 92.46 | 87.41 | 154.91 |
Operating Income | -36.4 | -52.15 | -26.16 | -43.74 | -62.31 | -39.38 |
Interest Expense | -1.32 | -1.42 | -1.78 | -2.23 | -1.11 | -0.13 |
Interest & Investment Income | 3.74 | 4.24 | 6.76 | 7.69 | 3.47 | 0.21 |
Earnings From Equity Investments | -5.96 | -5.28 | -1.08 | -4.93 | -1.58 | 0.18 |
Other Non Operating Income (Expenses) | -9.82 | 11.13 | 29.61 | - | - | - |
EBT Excluding Unusual Items | -49.75 | -43.49 | 7.35 | -43.21 | -61.53 | -39.12 |
Gain (Loss) on Sale of Investments | -3.45 | -2.67 | 0.26 | 1.15 | -0.51 | 2.56 |
Gain (Loss) on Sale of Assets | -0.38 | -0.42 | -0.44 | -0.46 | -0.03 | 5.96 |
Asset Writedown | -0.04 | -0.04 | - | - | -10.84 | - |
Pretax Income | -53.62 | -46.61 | 7.17 | -42.53 | -72.91 | -30.6 |
Earnings From Continuing Operations | -53.62 | -46.61 | 7.17 | -42.53 | -72.91 | -30.6 |
Earnings From Discontinued Operations | 0.89 | 0.89 | - | -18.79 | -38.73 | - |
Net Income | -52.73 | -45.72 | 7.17 | -61.32 | -111.64 | -30.6 |
Net Income to Common | -52.73 | -45.72 | 7.17 | -61.32 | -111.64 | -30.6 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 20 | 13 | 7 | 4 | 3 | 2 |
Shares Outstanding (Diluted) | 20 | 13 | 7 | 4 | 3 | 2 |
Shares Change | 128.47% | 86.32% | 79.20% | 31.11% | 49.77% | 12.79% |
EPS (Basic) | -2.59 | -3.56 | 1.05 | -15.96 | -38.10 | -15.64 |
EPS (Diluted) | -2.59 | -3.56 | 1.04 | -15.96 | -38.10 | -15.64 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -51.94 | -65.93 | -58.7 | -86.07 | -49.07 | -15.91 |
Free Cash Flow Per Share | -2.55 | -5.14 | -8.53 | -22.41 | -16.75 | -8.13 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -80.78% | -152.19% | -38.08% | -89.76% | -248.26% | -34.08% |
Profit Margin | -117.04% | -133.45% | 10.43% | -125.84% | -444.80% | -26.49% |
Free Cash Flow Margin | -115.27% | -192.41% | -85.44% | -176.64% | -195.52% | -13.77% |
EBITDA | -35.15 | -50.68 | -22.76 | -36.92 | -54.51 | -30.4 |
EBITDA Margin | -78.01% | -147.91% | -33.13% | -75.77% | -217.19% | -26.31% |
D&A For EBITDA | 1.25 | 1.47 | 3.4 | 6.82 | 7.8 | 8.98 |
EBIT | -36.4 | -52.15 | -26.16 | -43.74 | -62.31 | -39.38 |
EBIT Margin | -80.78% | -152.19% | -38.08% | -89.76% | -248.26% | -34.08% |